Successful AVERT PRETERM TRIAL Results
The AVERT PRETERM TRIAL results were published on the front cover of the July issue of the International peer-reviewed journal diagnostics, showing improved health risks of babies in asymptomatic pregnant mothers.
Increased Awareness and Engagement
The first email campaign had an open rate of 9%, the second 48%, and the third 70%, indicating effective engagement with medical professionals.
Significant Increase in Website Traffic
The preterm.com site saw a 227% traffic increase in September compared to last year, following the availability of the PreTRM Test for order online.
Strong Cash Position
As of September 30, 2024, the company had cash, cash equivalents, and available-for-sale securities of approximately $74.3 million, with a projected year-end cash balance of approximately $68 million.